

浏览全部资源
扫码关注微信
1.北京中医药大学 中医学院,北京 100029
2.北京中医药大学 北京中医药研究院,北京 100029
3.国家中医药管理局 名医名方重点研究室,北京 100029
4.国家药品监督管理局 药品审评中心,北京 100022
Received:04 October 2020,
Published Online:20 January 2021,
Published:20 March 2021
移动端阅览
刘珊,苏泽琦,刘逍遥等.基于PubMed和Web of Science数据库对中医药治疗慢性萎缩性胃炎现状的文献分析[J].中国实验方剂学杂志,2021,27(06):149-158.
LIU Shan,SU Ze-qi,LIU Xiao-yao,et al.Literature Study on Current Status of Traditional Chinese Medicine for Chronic Atrophic Gastritis Based on PubMed and Web of Science Databases[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(06):149-158.
刘珊,苏泽琦,刘逍遥等.基于PubMed和Web of Science数据库对中医药治疗慢性萎缩性胃炎现状的文献分析[J].中国实验方剂学杂志,2021,27(06):149-158. DOI: 10.13422/j.cnki.syfjx.20210319.
LIU Shan,SU Ze-qi,LIU Xiao-yao,et al.Literature Study on Current Status of Traditional Chinese Medicine for Chronic Atrophic Gastritis Based on PubMed and Web of Science Databases[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(06):149-158. DOI: 10.13422/j.cnki.syfjx.20210319.
目的
2
梳理和总结中医药治疗慢性萎缩性胃炎(CAG)的研究现状,为相关研究提供一定借鉴和指导,也为进一步了解中医药及应用中医药治疗CAG提供科学证据。
方法
2
检索PubMed和Web of Science数据库自建库至2020年8月31日收录的有关中医药治疗CAG的相关文献,根据纳入与排除标准,对文献进行筛选,纳入符合条件的临床随机对照试验和动物实验,并对纳入研究进行信息提取、归纳和整理。
结果
2
该研究共纳入中医药治疗CAG的临床随机对照试验4篇,动物实验21篇,包含复方研究13篇,单味药研究3篇,以及中药单体研究5篇。临床随机对照试验表明中医药在改善患者胃黏膜病理状态、临床症状等方面作用良好。但存在研究质量参差不齐、胃黏膜病理诊断标准及临床有效率评价标准不统一的问题。动物实验主要以药物作用机制研究为主,其研究结果表明了中医药治疗CAG具有多靶点的作用特点。但CAG动物模型制备、阳性药选择、药物干预方式和干预周期在不同实验中缺乏一致性,是动物实验研究中存在的问题。
结论
2
中医药治疗CAG的疗效逐渐获得全球认可,但在研究方法方面仍需进一步规范及统一。今后还需高质量的临床试验及规范的动物实验,对中药干预CAG的恶性进展时机、有效成分及作用机制等进行深入研究,为充分认识和发挥中医药治疗CAG贡献力量。
Objective
2
To review and summarize the current research status of traditional Chinese medicine(TCM) for the treatment of chronic atrophic gastritis(CAG),provide references and hints for relevant studies,and contribute to the further understanding of TCM and the application of TCM in the treatment of CAG with scientific evidence.
Method
2
The PubMed and Web of Science databases were searched for relevant literature on the treatment of CAG with TCM from their establishment to August 31,2020. Eligible randomized controlled trials (RCTs) and animal studies were included according to the inclusion and exclusion criteria,and then the information of the included studies was extracted,summarized,and organized for further analysis.
Result
2
A total of 4 RCTs and 21 animal studies (including 13 papers on compound studies,3 papers on single herb studies,and 5 papers on monomer studies) about TCM treatment for CAG were included in this study. RCTs showed that TCM could work well in improving the pathological state of gastric mucosa and clinical symptoms in patients. However,there were problems of low study quality,and non-uniform diagnostic criteria for gastric mucosal pathology and clinical efficiency evaluation. Animal experiments mainly focused on the study of drug mechanism exploration,and their results showed that TCM treatment of CAG was characterized by multi-target action. However,the animal experiments also had some problems such as inconsistence of CAG animal model establishment,positive drug selection,drug intervention methods as well as intervention cycles among different experiments.
Conclusion
2
The efficacy of TCM in the treatment of CAG has gradually gained global recognition,but there is still a need for further standardization and unification of research methods. In the future,high-quality clinical trials and standardized animal experiments are still needed to conduct in-depth studies on the time for intervention,intervention methods,active ingredients and mechanisms of TCM,so as to make contributions to the full understanding and application of TCM in the treatment of CAG.
LIBANIO D , MARCOS-PINTO R , AREIA M , et al . Management of epithelial precancerous conditions and lesions in the stomach (MAPS Ⅱ):European Society of Gastrointestinal Endoscopy(ESGE),European Helicobacter and Microbiota Study Group (EHMSG),European Society of Pathology(ESP),and Sociedade Portuguesa de Endoscopia Digestiva(SPED) guideline update 2019 [J]. Endoscopy , 2019 , 51 ( 4 ): 365 - 388 .
CORREA P . Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention [J]. Cancer Res , 1992 , 52 ( 24 ): 6735 - 6740 .
PHD B B M F , ME F J , PHD S M M I , et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2018 , 68 ( 6 ): 394 - 424 .
ANDERSON F W , CAMARGO C M , FRAUMENI F J , et al . Age-specific trends in incidence of noncardia gastric cancer in US adults [J]. JAMA , 2010 , 303 ( 17 ): 1723 - 1728 .
STRONG V E , RUSSO A , YOON S S , et al . Comparison of young patients with gastric cancer in the United States and China [J]. Ann Surg Oncol , 2017 , 24 ( 13 ): 3964 - 3971 .
JOOSSENS J V , HILL M J , ELLIOTT P , et al . Dietary salt,nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group [J]. Int J Epidemiol , 1996 , 25 ( 3 ): 494 - 504 .
WESSLER S , KRISCH L M , ELMER D P , et al . From inflammation to gastric cancer-the importance of Hedgehog/GLI signaling in Helicobacter pylori -induced chronic inflammatory and neoplastic diseases [J]. Cell Commun Signal , 2017 , 15 ( 1 ): 15 .
REDÉEN S , PETERSSON F , KECHAGIAS S , et al . Natural history of chronic gastritis in a population-based cohort [J]. Scand J Gastroenterol , 2010 , 45 ( 5 ): 540 - 549 .
YOON H , KIM N . Diagnosis and management of high risk group for gastric cancer [J]. Gut and Liver , 2015 , 9 ( 1 ): 5 - 17 .
TATSUGAMI M , ITO M , TANAKA S , et al . Bile acid promotes intestinal metaplasia and gastric carcinogenesis [J]. Cancer Epidemiol Biomarkers Prev , 2012 , 21 ( 11 ): 2101 - 2107 .
BERNSTEIN H , BERNSTEIN C , PAYNE C M , et al . Bile acids as carcinogens in human gastrointestinal cancers [J]. Mutat Res , 2005 , 589 ( 1 ): 47 - 65 .
FOCK K M , TALLEY N , MOAYYEDI P , et al . Asia-Pacific consensus guidelines on gastric cancer prevention [J]. J Gastroenterol Hepatol , 2008 , 23 ( 3 ): 351 - 365 .
LI Z , WU C , LI L , et al . Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy:A meta-analysis [J]. Saudi J Gastroenterol , 2017 , 23 ( 4 ): 222 - 228 .
SONG H , ZHU J , LU D . Long-term proton pump inhibitor(PPI) use and the development of gastricpre-malignant lesions [J]. Cochrane Database Syst Rev , 2014 ( 12 ): CD10623 .
ESLAMI L , NASSERI-MOGHADDAM S . Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions? [J]. Arch Iran Med , 2013 , 16 ( 8 ): 449 - 458 .
DENG X , LIU Z W , WU F S , et al . A clinical study of weining granules in the treatment of gastric precancerous lesions [J]. J Tradit Chin Med , 2012 , 32 ( 2 ): 164 - 172 .
TANG X D , ZHOU L Y , ZHANG S T , et al . Randomized double-blind clinical trial of Moluodan(摩罗丹) for the treatment of chronic atrophic gastritis with dysplasia [J]. Chin J Integr Med , 2016 , 22 ( 1 ): 9 - 18 .
WENG W A , YU X X . Effect of a combination of Xiaochaihu decoction and teprenone on peripheral blood T lymphocytes in chronic atrophic gastritis,and on expression of COX-2 in gastric mucosa [J]. Trop J Pharm Res , 2019 , 17 ( 10 ): 2007 - 2012 .
LI H , WANG H , WANG G , et al . Treatment of gastric precancerous lesions with Weiansan .[J]. World J Gastroentero , 2006 , 12 ( 33 ): 5389 - 5392 .
WANG X , XU J , ZHANG X , et al . Effects of Jinlongshe granules on gastric precancerous lesions in rats and its mechanism [J]. Int J Clin Exp Pathol , 2020 , 13 ( 5 ): 846 - 853 .
ZHANG Y , LI C , SUN S , et al . Screening and identification of molecular targets involved in preventing gastric precancerous lesions in chronic atrophic gastritis by Qilianshupi decoction [J]. Evid Based Complement Alternat Med , 2019 , 2019 : 5804710 .
ZENG J H , PAN H F , LIU Y Z , et al . Effects of Weipixiao(胃痞消) on Wnt pathway-associated proteins in gastric mucosal epithelial cells from rats with gastric precancerous lesions [J]. Chin J Integr Med , 2016 , 22 ( 4 ): 267 - 275 .
ZENG J , YAN R , PAN H , et al . Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions [J]. BMC Complement Altern Med , 2018 , 18 ( 1 ): 250 .
CAI T , ZHANG C , ZENG X , et al . Protective effects of Weipixiao decoction against MNNG-induced gastric precancerous lesions in rats [J]. Biomed Pharmacother , 2019 , 120 : 109427 .
LIU Y , JIN Z , QIN X , et al . Urinary metabolomics research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats based on 1 H-NMR and UPLC-Q/TOF MS [J]. J Pharm Pharmacol , 2020 , 72 ( 5 ): 748 - 760 .
LIU Y , HU Y , WANG G , et al . Huangqi Jianzhong Tang ameliorated phospholipase A 2 and glycerophospholipids metabolism against chronic atrophic gastritis rats [J]. J Liq Chromatogr R T , 2018 , 41 ( 19/20 ): 1082 - 1091 .
LIU Y , XU W , WANG G , et al . Material basis research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats through integration of urinary metabonomics and SystemsDock [J]. J Ethnopharmacol , 2018 , 223 : 1 - 9 .
LIU Y , CUI J , HU Y , et al . Integrating untargeted metabonomics,partial least square regression analysis and MetPA to explore the targeted pathways involved into Huangqi Jiangzhong Tang against chronic atrophic gastritis rats [J]. Chemometr Intell Lab , 2017 , 164 : 16 - 25 .
XU J , SHEN W , PEI B , et al . Xiao Tan He Wei Decoction reverses MNNG-induced precancerous lesions of gastric carcinoma in vivo and vitro:Regulation of apoptosis through NF- κ B pathway [J]. Biomed Pharmacother , 2018 , 108 : 95 - 102 .
YIN J , YI J , YANG C , et al . Weiqi decoction attenuated chronic atrophic gastritis with precancerous lesion through regulating microcirculation disturbance and HIF-1α signaling pathway [J]. Evid Based Complement Alternat Med , 2019 , 2019 : 2651037 .
SHEN SHU-WEN , YUWEN YA , ZHANG ZHEN-LU , et al . Effect of Jinguo Weikang capsule (金果胃康胶囊) on proto-oncogene expression of gastric mucosa in rats with gastric precancerous lesions [J]. Chin J Integr Med , 2008 , 14 ( 3 ): 212 - 216 .
LI S , HUANG M , CHEN Q , et al . Confirming the effects of Qinghuayin against chronic atrophic gastritis and a preliminary observation of the involved inflammatory signaling pathways: an in vivo study [J]. Evid Based Complement Alternat Med , 2018 , 2018 : 4905089 .
JIANG X Y , QIAN L P , ZHENG X J , et al . Interventional effect of Ginkgo biloba extract on the progression of gastric precancerous lesions in rats [J]. J Dig Dis , 2009 , 10 ( 4 ): 293 - 299 .
ZHU Y , HU L , LI P , et al . Effects of celastrus orbiculatus on epithelial mesenchymal transition in gastric mucosal epithelial cells by inhibiting Lgr5 expression from rats with gastric precancerous lesions [J]. Am J Chin Med , 2018 , 46 ( 5 ): 1129 - 1143 .
JEONG M , PARK J , HAN Y , et al . Dietary intervention of artemisia and green tea extracts to rejuvenate Helicobacter pylori -associated chronic atrophic gastritis and to prevent tumorigenesis [J]. Helicobacter , 2016 , 21 ( 1 ): 40 - 59 .
ZHANG J , WANG H . Morroniside protects against chronic atrophic gastritis in rat via inhibiting inflammation and apoptosis [J]. Am J Transl Res , 2019 , 11 ( 9 ): 6016 - 6023 .
CAI T , ZHANG C , ZHAO Z , et al . The gastric mucosal protective effects of astragaloside Ⅳ in mnng-induced GPL rats [J]. Biomed Pharmacother , 2018 , 104 : 291 - 299 .
ZHANG C , CAI T , ZENG X , et al . Astragaloside Ⅳ reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: regulation on glycolysis through miRNA-34a/LDHA pathway [J]. Phytother Res , 2018 , 32 ( 7 ): 1364 - 1372 .
ZHU X , LIU S , ZHOU J , et al . Effect of Astragalus polysaccharides on chronic atrophic gastritis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats [J]. Drug Res(Stuttg) , 2013 , 63 ( 11 ): 597 - 602 .
ZHAO Y , SUN Y , WANG G , et al . Dendrobium Officinale Polysaccharides protect against MNNG-Induced PLGC in rats via ACTIVATING the NRF2 and antioxidant enzymes HO-1 and NQO-1 [J]. Oxid Med Cell Longev , 2019 , 2019 : 9310245 .
SÁENZ J B , MILLS J C . Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer [J]. Nat Rev Gastroenterol Hepatol , 2018 , 15 ( 5 ): 257 - 273 .
ZHANG X Y , ZHANG P Y , ABOULSOUD M A . From inflammation to gastric cancer: role of Helicobacter pylori [J]. Oncol Lett , 2017 , 13 ( 2 ): 543 - 548 .
ZENG J , YAN R , PAN H , et al . Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions [J]. BMC Complement Altern Med , 2018 , 18 ( 1 ): 250 .
PLUMMER M , VIVAS J , LOPEZ G , et al . Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population [J]. J Natl Cancer Inst , 2007 , 99 ( 2 ): 137 - 146 .
JACOBS E J , CONNELL C J , MCCULLOUGH M L , et al . Vitamin C,vitamin E,and multivitamin supplement use and stomach cancer mortality in the cancer prevention study Ⅱ cohort [J]. Cancer Epidemiol Biomarkers Prev , 2002 , 11 ( 1 ): 35 - 41 .
0
Views
20
下载量
4
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621